TNSN05067A1 - Acetyl 2-hydroxy- 1,3 diaminoalkanes - Google Patents
Acetyl 2-hydroxy- 1,3 diaminoalkanesInfo
- Publication number
- TNSN05067A1 TNSN05067A1 TNP2005000067A TNSN05067A TNSN05067A1 TN SN05067 A1 TNSN05067 A1 TN SN05067A1 TN P2005000067 A TNP2005000067 A TN P2005000067A TN SN05067 A TNSN05067 A TN SN05067A TN SN05067 A1 TNSN05067 A1 TN SN05067A1
- Authority
- TN
- Tunisia
- Prior art keywords
- diaminoalkanes
- acetyl
- hydroxy
- compounds
- disclosed
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
DISCLOSED ARE COMPOUNDS OF THE FORMULA : (I) WHERE VARIABLES Z, X, R15, R2, R3, AND Rc ARE DEFINED HEREIN. COMPOUNDS DISCLOSED HEREIN ARE INHIBITORS OF THE BETA-SECRETASE ENZYME AND ARE THEREFORE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISEASES CHARACTERIZED BY DEPOSITION OF A BETA PEPTIDE IN A MAMMAL.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40945302P | 2002-09-10 | 2002-09-10 | |
PCT/US2003/028503 WO2004024081A2 (en) | 2002-09-10 | 2003-09-10 | Acetyl 2-hydroxy-1,3 diaminoalkanes |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN05067A1 true TNSN05067A1 (en) | 2007-05-14 |
Family
ID=35353421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2005000067A TNSN05067A1 (en) | 2002-09-10 | 2005-03-08 | Acetyl 2-hydroxy- 1,3 diaminoalkanes |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN100384824C (en) |
AP (1) | AP2005003247A0 (en) |
CR (1) | CR7720A (en) |
TN (1) | TNSN05067A1 (en) |
ZA (1) | ZA200501991B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010030538A1 (en) * | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments |
DE102011087987A1 (en) * | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments |
CN109790079B (en) * | 2016-07-29 | 2022-06-03 | 香港科技大学 | C (sp) of organozinc reagents and heterocyclic (pseudo) halides3)-C(sp2) Cross-coupling reaction |
EP3490607A4 (en) * | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Compounds and compositions and uses thereof |
JP7191085B2 (en) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | Isochroman compounds and uses thereof |
CN113189089B (en) * | 2021-03-19 | 2022-05-17 | 四川轻化工大学 | Ozone detection reagent and preparation device and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482947A (en) * | 1990-11-19 | 1996-01-09 | Talley; John J. | Retroviral protease inhibitors |
AU749281B2 (en) * | 1997-02-04 | 2002-06-20 | Regents Of The University Of California, The | Nanomolar, non-peptide inhibitors of cathepsin D |
-
2003
- 2003-09-10 CN CNB03824988XA patent/CN100384824C/en not_active Expired - Fee Related
- 2003-09-10 AP AP2005003247A patent/AP2005003247A0/en unknown
-
2005
- 2005-03-08 TN TNP2005000067A patent/TNSN05067A1/en unknown
- 2005-03-09 ZA ZA200501991A patent/ZA200501991B/en unknown
- 2005-03-09 CR CR7720A patent/CR7720A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1694870A (en) | 2005-11-09 |
AP2005003247A0 (en) | 2005-03-31 |
CN100384824C (en) | 2008-04-30 |
CR7720A (en) | 2005-07-14 |
ZA200501991B (en) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004024081A3 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
WO2003103653A8 (en) | Methods of treating alzheimer's disease using aryl alkanoic acid amides | |
WO2005095326A3 (en) | 2-amino- and 2-thio-substituted 1,3-diaminopropanes | |
MXPA04000328A (en) | Statine derivatives for the treatment of alzheimer's disease. | |
WO2002076440A3 (en) | Methods of treating alzheimer's disease with piperidin derivates | |
BR0214035A (en) | Compound | |
MXPA05011150A (en) | (HETERO) ARYLAMIDE 2-HYDROXY-3-DIAMINOALKANES FOR USE IN THE TREATMENT OF ALZHEIMERaCOES DISEASE. | |
NZ516599A (en) | 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands | |
WO2004022523A3 (en) | 1, 3-diamino-2-hydroxypropane prodrug derivatives | |
NO20032801L (en) | Thiazole derivatives for the treatment of PPAR-related disorders | |
MXPA04003245A (en) | Hydroxypropylamines. | |
TW200505418A (en) | Phenacyl 2-hydroxy-3-diaminoalkanes | |
SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
RS53704A (en) | Alpha-(n-sulphonamido)acetamide derivatives as betha- amyloid inhibitors | |
MXPA05002420A (en) | Thiazole compounds for the treatment of neurodegenerative disorders. | |
CA2379747A1 (en) | Novel succinate derivative compounds useful as cysteine protease inhibitors | |
TW200505828A (en) | Substituted ureas and carbamates useful in the treatment of alzheimer's disease | |
MXPA04002785A (en) | Substituted amines for the treatment of alzheimer's disease. | |
TNSN05067A1 (en) | Acetyl 2-hydroxy- 1,3 diaminoalkanes | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
MXPA03011466A (en) | Macrocycles useful in the treatment of alzheimer's disease. | |
BR0213138A (en) | Methods of treating or preventing alzheimer's disease and a disease distinguished by beta-amyloid deposition in the brain, treating a patient who has, or preventing a patient from contracting a disease or condition, producing a beta-secretase complex and inhibit beta-amyloid plaque production in an animal, composition and use of a compound | |
AU2002356991A1 (en) | Amino acid derivatives useful for the treatment of alzheimer's disease | |
MXPA03011399A (en) | Methods of treating alzheimer's disease. | |
MXPA03011502A (en) | Substituted aminoalcohols useful in treatment of alzheimer's disease. |